Decision comes after the Supreme Court’s order came on a petition filed by the makers of these medicines. A bench of Justices R F Nariman and Indu Malhotra lifted the ban on Piramal Healthcare’s Saridon, GlaxoSmithKline’s Piriton, Juggat Pharma’s Dart and another drug, the details of which could not be immediately known.
The companies approached the top court after the government banned the manufacture, sale and distribution of 328 fixed-dose combinations (FDCs) drugs for human use with immediate effect to stop their “illegal use”. During the hearing, the companies argued that these FDCs were being manufactured since before 1988 and as the apex court had earlier exempted 15 such combinations from the government’s ban, the same exemptions should be extended to these brands, a report in The Economic Times quoted two lawyers as saying. While lifting the ban, the Supreme Court sought Centre’s reply on petitions against the order to ban FDCs manufactured before 1988 and said the stay on the Centre’s notification, banning the three drugs, remains till it decides on the issue. Last week, the health ministry banned 328 FDCs, including Saridon and skin cream Panderm.